BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37947418)

  • 1. Microbe-derived uremic solutes enhance thrombosis potential in the host.
    Nemet I; Funabashi M; Li XS; Dwidar M; Sangwan N; Skye SM; Romano KA; Cajka T; Needham BD; Mazmanian SK; Hajjar AM; Rey FE; Fiehn O; Tang WHW; Fischbach MA; Hazen SL
    mBio; 2023 Nov; 14(6):e0133123. PubMed ID: 37947418
    [No Abstract]   [Full Text] [Related]  

  • 2. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
    Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
    J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inulin-type fructan intervention restricts the increase in gut microbiome-generated indole in patients with peritoneal dialysis: a randomized crossover study.
    Li L; Xiong Q; Zhao J; Lin X; He S; Wu N; Yao Y; Liang W; Zuo X; Ying C
    Am J Clin Nutr; 2020 May; 111(5):1087-1099. PubMed ID: 31942927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
    Nemet I; Li XS; Haghikia A; Li L; Wilcox J; Romano KA; Buffa JA; Witkowski M; Demuth I; König M; Steinhagen-Thiessen E; Bäckhed F; Fischbach MA; Tang WHW; Landmesser U; Hazen SL
    Eur Heart J; 2023 Aug; 44(32):3085-3096. PubMed ID: 37342006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the oral adsorbent AST-120 on fecal p-cresol and indole levels and on the gut microbiota composition.
    Sato E; Hosomi K; Sekimoto A; Mishima E; Oe Y; Saigusa D; Ito S; Abe T; Sato H; Kunisawa J; Niwa T; Takahashi N
    Biochem Biophys Res Commun; 2020 May; 525(3):773-779. PubMed ID: 32147096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can our microbiome break our hearts? Collaborative production of
    Machado Ribeiro TR; Brito CB; Byndloss MX
    mBio; 2024 Feb; 15(2):e0269223. PubMed ID: 38226819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolome and Its Emerging Role in Chronic Kidney Diseases.
    Fryc J; Naumnik B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota generation of protein-bound uremic toxins and related metabolites is not altered at different stages of chronic kidney disease.
    Gryp T; De Paepe K; Vanholder R; Kerckhof FM; Van Biesen W; Van de Wiele T; Verbeke F; Speeckaert M; Joossens M; Couttenye MM; Vaneechoutte M; Glorieux G
    Kidney Int; 2020 Jun; 97(6):1230-1242. PubMed ID: 32317112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-based inhibition of gut microbial tryptophanases reduces serum indoxyl sulfate.
    Graboski AL; Kowalewski ME; Simpson JB; Cao X; Ha M; Zhang J; Walton WG; Flaherty DP; Redinbo MR
    Cell Chem Biol; 2023 Nov; 30(11):1402-1413.e7. PubMed ID: 37633277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the impact of gut microbiota on uremic solute accumulation by a CE-TOFMS-based metabolomics approach.
    Mishima E; Fukuda S; Mukawa C; Yuri A; Kanemitsu Y; Matsumoto Y; Akiyama Y; Fukuda NN; Tsukamoto H; Asaji K; Shima H; Kikuchi K; Suzuki C; Suzuki T; Tomioka Y; Soga T; Ito S; Abe T
    Kidney Int; 2017 Sep; 92(3):634-645. PubMed ID: 28396122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Dietary Protein Concentration on the Fecal Microbiome and Serum Concentrations of Gut-Derived Uremic Toxins in Healthy Adult Cats.
    Summers S; Quimby J; Gagné J; Lappin M
    Vet Sci; 2023 Aug; 10(8):. PubMed ID: 37624284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair.
    Dou L; Bertrand E; Cerini C; Faure V; Sampol J; Vanholder R; Berland Y; Brunet P
    Kidney Int; 2004 Feb; 65(2):442-51. PubMed ID: 14717914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance Hemodialysis: Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins, A Pilot Study (PLAN Study).
    Marzocco S; Fazeli G; Di Micco L; Autore G; Adesso S; Dal Piaz F; Heidland A; Di Iorio B
    J Clin Med; 2018 Sep; 7(10):. PubMed ID: 30274359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein-bound uremic toxins impaired mitochondrial dynamics and functions.
    Sun CY; Cheng ML; Pan HC; Lee JH; Lee CC
    Oncotarget; 2017 Sep; 8(44):77722-77733. PubMed ID: 29100420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
    Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
    Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Harrison MA; Faulds-Pain A; Kaur H; Dupuy B; Henriques AO; Martin-Verstraete I; Wren BW; Dawson LF
    J Bacteriol; 2020 Aug; 202(18):. PubMed ID: 32631945
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors associated with blood concentrations of indoxyl sulfate and p-cresol in patients undergoing peritoneal dialysis.
    Lee CT; Kuo CC; Chen YM; Hsu CY; Lee WC; Tsai YC; Ng HY; Kuo LC; Chiou TT; Yang YK; Cheng BC; Chen JB
    Perit Dial Int; 2010; 30(4):456-63. PubMed ID: 20338972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P
    Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
    Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.
    Bao M; Zhang P; Guo S; Zou J; Ji J; Ding X; Yu X
    Front Cell Infect Microbiol; 2022; 12():639624. PubMed ID: 36237423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.